Working with commercial companies for the sustainability of health informatics research in the veterinary sector.
Lead Research Organisation:
University of Liverpool
Department Name: Institute of Infection and Global Health
Abstract
Abstracts are not currently available in GtR for all funded research. This is normally because the abstract was not required at the time of proposal submission, but may be because it included sensitive information such as personal details.
Organisations
Description | We now understand how to engage with commercial companies as a way of commercialising our research. We also have a demo version of a dashboard to share with commercial companies. |
Exploitation Route | We are seeking to develop further our offer to the commercial sector, building on the exact market research undertaken in this grant. |
Sectors | Pharmaceuticals and Medical Biotechnology |
Description | We are now generating some (modest) commercial income from SAVSNET data. This work has included both UK bsaed and international companies (eg USA, France). Total income from such projects now exceeds £100,000 - these monies are used to contribute to ongoing sustainability of the project.We hope to continue to grow these in the coming years. |
First Year Of Impact | 2018 |
Sector | Pharmaceuticals and Medical Biotechnology |
Impact Types | Economic Policy & public services |
Description | Launch of Pharmasee, to provide data on product use by vets to commercial companies. |
Form Of Engagement Activity | A talk or presentation |
Part Of Official Scheme? | No |
Geographic Reach | National |
Primary Audience | Industry/Business |
Results and Impact | To promote SAVSNET data as a valuable tool for commercial companies to better understand their product use. We call this "Pharmasee". Income generated from such SAVSNET-based market intelligence is used for sustainability. The presentation pitch to companies was entirely based on the market research carried out as part of this BBSRC award. To date, two companies have commissioned work, and a second is discussing working with us. |
Year(s) Of Engagement Activity | 2020 |